Tech Company Financing Transactions
Aronora Funding Round
NYBC Ventures participated in a capital raise for Aronora. This venture round was announced on 10/16/2023.
Transaction Overview
Company Name
Announced On
10/16/2023
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
NYBC Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds for team expansion, manufacturing, and regulatory activities as they prepare for late-stage clinical development of their lead investigational products E-WE thrombin (AB002) and Gruticibart (AB023). Both drug candidates have completed phase 2a clinical trials, with compelling top-line data.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1818 Southwest 4th Avenue 102
Portland, OR 97201
USA
Portland, OR 97201
USA
Phone
Undisclosed
Website
Email Address
Overview
Aronora is a translational biotechnology company (aronorabio.com) engaged in the development of proprietary biologic therapeutics, including recombinant monolconal antibodies and enzymes. Rational design of our innovative therapeutic agents is expected to result in drug products that reduce the progression and growth of life-threatening blood clots without the detrimental bleeding side effects that characterize all currently marketed antithrombotic drugs. Our products are intended to be used in difficult-to-treat, severe, rapidly progressing, or catastrophic thrombotic blood clotting diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Erik Tucker
Browse more venture capital transactions:
Prev: 10/16/2023: Creative Force venture capital transaction
Next: 10/16/2023: Nvasc venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs